245 results on '"Rasmussen, Theodore P."'
Search Results
2. Nephrotoxicity of marketed antisense oligonucleotide drugs
3. Modeling the kidney with human pluripotent cells: Applications for toxicology and organ repair
4. Conserved Higher-Order Chromatin Regulates NMDA Receptor Gene Expression and Cognition
5. Identification and Functional Characterization of Alternative Transcripts of LncRNA HNF1A-AS1 and Their Impacts on Cell Growth, Differentiation, Liver Diseases, and in Response to Drug Induction.
6. Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
7. Pluripotent cells for the assessment of chemically induced teratogenesis and developmental toxicology
8. Contributors
9. Variability in expression of the human MDR1 drug efflux transporter and genetic variation of the ABCB1 gene: implications for drug-resistant epilepsy
10. Stem Cells in Birth Defects Research and Developmental Toxicology
11. Dynamic Relocalization of Histone MacroH2A1 from Centrosomes to Inactive X Chromosomes during X Inactivation
12. Genetic Variations Associated with Anti-Tuberculosis Drug-Induced Liver Injury
13. Correlations of Long Noncoding RNA HNF4A-AS1 Alternative Transcripts with Liver Diseases and Drug Metabolism
14. Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
15. Stem Cells in Birth Defects Research and Developmental Toxicology
16. The Basics of Stem Cells and Their Utility as Platforms to Model Teratogen Action and Human Developmental and Degenerative Disorders
17. Belzutifan (Welireg™) for von Hippel Lindau disease
18. Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies
19. Absorption, Distribution, Metabolism, and Excretion of FDA‐approved Antisense Oligonucleotide Drugs
20. Contributors
21. Genomic Medicine and Lipid Metabolism
22. Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
23. Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
24. The Epigenetics of Nuclear Reprogramming to Pluripotency
25. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions
26. Efficient and Rapid generation of anti-aging neural stem cells by direct conversion Fibroblasts with A Single microRNA
27. The growth of siRNA-based therapeutics: Updated clinical studies
28. Chapter 7 - Pluripotent cells for the assessment of chemically induced teratogenesis and developmental toxicology
29. Epigenetics, Nuclear Organization and Gene Function: With Implications of Epigenetic Regulation and Genetic Architecture for Human Development and Health. By John C. Lucchesi. Oxford and New York: Oxford University Press. $100.00 (hardcover); $49.95 (paper). xviii + 286 p.; ill.; index. ISBN: 978-0-19-883120-4 (hc); 978-0-19-883121-1 (pb). 2019.
30. Quantitation of Nucleosome Acetylation and Other Histone Posttranslational Modifications Using Microscale NU-ELISA
31. lnc‐RHL, a novel long non‐coding RNA required for the differentiation of hepatocytes from human bipotent progenitor cells
32. A maternal store of macroH2A is removed from pronuclei prior to onset of somatic macroH2A expression in preimplantation embryos
33. Dedifferentiated adipocyte-derived progeny cells (DFAT cells): Potential stem cells of adipose tissue
34. Expression of Xist RNA is sufficient to initiate macrochromatin body formation
35. BRCA1 supports XIST RNA concentration on the inactive X chromosome
36. Evidence that miR-152-3p is a positive regulator of SETDB1-mediated H3K9 histone methylation and serves as a toggle between histone and DNA methylation
37. Emerging Therapeutic Modalities against COVID-19
38. HDAC3 overexpression and colon cancer cell proliferation and differentiation
39. Parallels between artificial reprogramming and the biogenesis of cancer stem cells: Involvement of lncRNAs
40. Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2
41. Expression Pattern of the Rett Syndrome Gene MeCP2 in Primate Prefrontal Cortex
42. Stem Cells in Development and Disease. Current Topics in Developmental Biology, Volume 107 Rendl Michael
43. Embryonic stem cell differentiation: A chromatin perspective
44. Chapter 5 - Genomic Medicine and Lipid Metabolism: LDL Targets and Stem Cell Research Approaches
45. Use of Human Embryoid Bodies for Teratology
46. Epigenetics and Development . Current Topics in Developmental Biology, Volume 104. Edited by Edith Heard . Academic Press. Amsterdam (The Netherlands) and Boston (Massachusetts): Elsevier. $210.00. xv + 334 p. + 16 pl.; ill.; index. ISBN: 978-0-12-416027-9. 2013.
47. Epigenetic Regulation and Epigenomics . Volumes 1 and 2. Advances in Molecular Biology and Medicine. Edited by Robert A. Meyers . Hoboken (New Jersey): Wiley-Blackwell. $539.95 (two-volume set). Volume 1: xx + 770 p.; ill.; no index and Volume 2: xx + pp. 771–1213; ill.; index. ISBN: 978-3-527-32682-2. 2012.
48. A standardized human embryoid body platform for the detection and analysis of teratogens
49. Stem Cells in Development and Disease. Current Topics in Developmental Biology, Volume 107. Edited by Michael Rendl. Academic Press. Amsterdam and Boston (Massachusetts): Elsevier. $210.00. xviii + 452 p. + 31 pl.; ill.; index. ISBN: 978-0-12-416022-4. 2014.
50. Int J Biol Sci
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.